PRACA PRZEGLĄDOWA
Osteoporosis in axial radiographic spondyloarthritis: diagnostic limitations of bone mineral density and the need for comprehensive fracture risk assessment
Więcej
Ukryj
1
Clinic of Rheumatology and Connective Tissue Diseases, Jan Biziel University Hospital No. 2 in Bydgoszcz, Poland
2
Collegium Medicum in Bydgoszcz, Poland
3
Department of Radiology, Jan Biziel University Hospital No. 2 in Bydgoszcz, Poland
4
Kliniczne Terapie Innowacyjne, Torun, Poland
5
Provincial Integrated Hospital of Ludwik Rydygier, Torun, Poland
6
Clinical Department of Orthopedics and Traumatology, Jan Biziel University Hospital No. 2 in Bydgoszcz, Poland
Data nadesłania: 28-07-2024
Data ostatniej rewizji: 10-09-2024
Data akceptacji: 04-10-2024
Data publikacji: 24-12-2024
Autor do korespondencji
Paweł Żuchowski
Department of Rheumatology and Connective Tissue Diseases, Dr Jan Biziel University Hospital No. 2 in Bydgoszcz, 75 Kornela Ujejskiego St., 85-168 Bydgoszcz, Poland
Reumatologia 2024;62(6):466-474
SŁOWA KLUCZOWE
DZIEDZINY
STRESZCZENIE
Axial radiographic spondyloarthritis (r-axSpA) is a chronic inflammatory joint disease that leads to a considerable decline in the quality of life of patients by impairment of function and mobility, which, in turn, brings about a deterioration of both physical and mental health. Osteoporosis (OP) is a significant issue in the course of r-axSpA. Fractures resulting from OP complicate the treatment of the underlying disease and reduce the quality of life of patients. The aim of this paper is to discuss currently available diagnostic methods for OP and highlight why the gold standard for diagnosis – the assessment of bone mineral density via dual-energy X-ray absorptiometry – is not sufficient for patients with r-axSpA.
REFERENCJE (42)
1.
Crossfield SSR, Marzo-Ortega H, Kingsbury SR, et al. Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades. RMD Open 2021; 7: e001888, DOI: 10.1136/rmdopen-2021-001888.
2.
Michelena X, López-Medina C, Marzo-Ortega H. Non-radiographic versus radiographic axSpA: what’s in a name? Rheumatology (Oxford) 2020; 59 (Suppl 4): iv18–iv24, DOI: 10.1093/rheumatology/keaa422.
3.
Parkinson JT, Foley ÉM, Jadon DR, Khandaker GM. Depression in patients with spondyloarthritis: prevalence, incidence, risk factors, mechanisms and management. Ther Adv Musculoskelet Dis 2020; 12: 1759720X20970028, DOI: 10.1177/1759720X20970028.
4.
Shevchuk S, Pavliuk O. The state of bone mineral density in men with ankylosing spondylitis and its relationship with the course of the disease. Reumatologia 2024; 62: 43–51, DOI: 10.5114/reum/184028.
5.
Khan MA, Khan MK, Kushner I. Survival among patients with ankylosing spondylitis: a life-table analysis. J Rheumatol 1981; 8: 86–90.
6.
Kobelt G, Andlin-Sobocki P, Brophy S, et al. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade). Rheumatology (Oxford) 2004; 43: 1158–1166, DOI: 10.1093/rheumatology/keh271.
7.
Silva BC, Leslie WD, Resch H, et al. Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 2014; 29: 518–530, DOI: 10.1002/jbmr.2176. Erratum in: J Bone Miner Res 2017; 32: 2319, DOI: 10.1002/jbmr.3218.
8.
Żuchowski P, Dura M, Jeka D, Waszczak-Jeka M. The applicability of trabecular bone score for osteoporosis diagnosis in ankylosing spondylitis. Rheumatol Int 2022; 42: 839–846, DOI: 10.1007/s00296-022-05109-0.
9.
Richards C, Hans D, Leslie WD. Trabecular Bone Score (TBS) predicts fracture in ankylosing spondylitis: the Manitoba BMD Registry. J Clin Densitom 2020; 23: 543–548, DOI: 10.1016/ j.jocd.2020.01.003.
10.
Kandregula S, Birk HS, Savardekar A, et al. Spinal fractures in ankylosing spondylitis: patterns, management, and complications in the United States – analysis of latest nationwide inpatient sample data. Neurospine 2021; 18: 786–797, DOI: 10.14245/ns.2142712.356.
11.
Sharif K, Tsur AM, Ben-Shabat N, et al. The risk of osteoporosis in patients with ankylosing spondylitis – a large retrospective matched cohort study. Med Clin (Barc) 2023; 160: 373–378, DOI: 10.1016/j.medcli.2022.10.013.
12.
Hu J, Wang Y, Ji X, et al. The prevalence of sarcopenia in spondyloarthritis patients: a meta-analysis. Arthritis Res Ther 2024; 26: 72, DOI: 10.1186/s13075-024-03299-5.
13.
Magrey M, Khan MA. Osteoporosis in ankylosing spondylitis. Curr Rheumatol Rep 2010; 12: 332–336, DOI: 10.1007/s11926-010-0122-1.
14.
Briot K, Roux C. Inflammation, bone loss and fracture risk in spondyloarthritis. RMD Open 2015; 1: e000052, DOI: 10.1136/rmdopen-2015-000052.
15.
Singh HJ, Nimarpreet K, Ashima, et al. Study of bone mineral density in patients with ankylosing spondylitis. J Clin Diagn Res 2013; 7: 2832–2835, DOI: 10.7860/JCDR/2013/6779.3770.
16.
Shevroja E, Reginster JY, Lamy O, et al. Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging. Osteoporos Int 2023; 34: 1501–1529, DOI: 10.1007/s00198-023-06817-4.
17.
Ho-Pham LT, Nguyen TV. Association between trabecular bone score and type 2 diabetes: a quantitative update of evidence. Osteoporos Int 2019; 30: 2079–2085, DOI: 10.1007/s00198-019-05053-z.
18.
Fang ML, Wu CS, Weng LC, Huang HL. Factors associated with depressive symptoms in patients with ankylosing spondylitis in Northern Taiwan. PLoS One 2019; 14: e0224298, DOI: 10.1371/journal.pone.0224298.
19.
Huang J, Bai H, Tan Q, et al. Instantaneous death risk, conditional survival and optimal surgery timing in cervical fracture patients with ankylosing spondylitis: A national multicentre retrospective study. Front Immunol 2022; 13: 971947, DOI: 10.3389/fimmu.2022.971947.
20.
Li N, Li XM, Xu L, et al. Comparison of QCT and DXA: osteoporosis detection rates in postmenopausal women. Int J Endocrinol 2013; 2013: 895474, DOI: 10.1155/2013/895474.
21.
Sözen T, Özışık L, Başaran NÇ. An overview and management of osteoporosis. Eur J Rheumatol 2017; 4: 46–56, DOI: 10.5152/eurjrheum.2016.048.
23.
Cohen A. Premenopausal osteoporosis. Endocrinol Metab Clin North Am 2017; 46: 117–133, DOI: 10.1016/j.ecl.2016.09.007.
24.
Xiongfeng T, Cheng Z, Meng H, et al. One novel phantom-less quantitative computed tomography system for auto-diagnosis of osteoporosis utilizes low-dose chest computed tomography obtained for COVID-19 screening. Front Bioeng Biotechnol 2022; 10: 856753, DOI: 10.3389/fbioe.2022.856753.
25.
Bartenschlager S, Cavallaro A, Pogarell T, et al. Opportunistic screening with CT: comparison of phantomless BMD calibration methods. J Bone Miner Res 2023; 38: 1689–1699, DOI: 10.1002/jbmr.4917.
26.
Dura M, Blumfield E, Żuchowski P, et al. The use of computed tomography to assess bone density in comparison to bone density assessment by DXA method. European Congress of Radiology. Vienna, 6-10 III 2014. Available at:
https://epos.myesr.org/poster/... (Access: 10.07.2024).
27.
Gazzotti S, Aparisi Gómez MP, Schileo E, et al. High-resolution peripheral quantitative computed tomography: research or clinical practice? Br J Radiol 2023; 96: 20221016.
28.
Al Refaie A, Baldassini L, Mondillo C, et al. Radiofrequency Echographic Multi Spectrometry (R.E.M.S.): New Frontiers for Ultrasound Use in the Assessment of Bone Status-A Current Picture. Diagnostics (Basel) 2023; 13: 1666, DOI: 10.3390/diagnostics13101666.
29.
Caffarelli C, Tomai Pitinca MD, Al Refaie A, et al. Ability of radiofrequency echographic multispectrometry to identify osteoporosis status in elderly women with type 2 diabetes. Aging Clin Exp Res 2022; 34: 121–127, DOI: 10.1007/s40520-021- 01889-w.
30.
Bojincă VC, Popescu CC, Decianu RD, et al. A novel quantitative method for estimating bone mineral density using B-mode ultrasound and radiofrequency signals – a pilot study on patients with rheumatoid arthritis. Exp Ther Med 2019; 18: 1661–1668, DOI: 10.3892/etm.2019.7746.
31.
Brance ML, Pons-Estel BA, Quagliato NJ, et al. Trabecular and cortical bone involvement in rheumatoid arthritis by DXA and DXA-based 3D modelling. Osteoporos Int 2021; 32: 705–714, DOI: 10.1007/s00198-020-05641-4.
32.
Leslie WD, Binkley N, Goel H, et al. FRAX® Adjustment Using Renormalized Trabecular Bone Score (TBS) from L1 Alone may be Optimal for Fracture Prediction: The Manitoba BMD Registry. J Clin Densitom 2023; 26: 101430, DOI: 10.1016/j.jocd. 2023.101430.
33.
Martineau P, Leslie WD, Johansson H, et al. In which patients does lumbar spine trabecular bone score (TBS) have the largest effect? Bone 2018; 113: 161–168, DOI: 10.1016/j.bone. 2018.05.026.
34.
Leslie WD, Aubry-Rozier B, Lamy O, Hans D. Manitoba Bone Density Program. TBS (trabecular bone score) and diabetes- related fracture risk. J Clin Endocrinol Metab 2013; 98: 602–609, DOI: 10.1210/jc.2012-3118.
35.
Braun J, Buehring B, Baraliakos X, et al. Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1. BMC Musculoskelet Disord 2021; 22: 1037, DOI: 10.1186/s12891-021-04930-1.
36.
Simon D, Minopoulou I, Kemenes S, et al. Baricitinib Improves Bone Properties and Biomechanics in Patients With Rheumatoid Arthritis: Results of the Prospective Interventional BARE BONE Trial. Arthritis Rheumatol 2023; 75: 1923–1934.
37.
Nam SW, Sung YK, Kim D, et al. The usefulness of trabecular bone score in patients with ankylosing spondylitis. Korean J Intern Med 2021; 36: 1211–1220, DOI: 10.3904/kjim.2020.065.
38.
Gielen E, Dupont J, Dejaeger M, Laurent MR. Sarcopenia, osteoporosis and frailty. Metabolism 2023; 145: 155638, DOI: 10.1016/j.metabol.2023.155638.
39.
Kedyk I, Stanislavchuk M. Clinical characteristics of ankylosing spondylitis patients depending on neuropathic pain. Reumatologia 2023; 61: 104–108, DOI: 10.5114/reum/163223.
40.
Lim GRS, Ng CH, Kwan YH, Fong W. Prevalence and risk factors for falls in patients with spondyloarthritis: a systematic review. Int J Rheum Dis 2021; 24: 623–632, DOI: 10.1111/1756-185X.14092.
41.
Ceolin C, Papa MV, Scagnellato L, et al. Is sarcopenia a real concern in ankylosing spondylitis? A systematic literature review. Eur Geriatr Med 2024; 15: 903–912, DOI: 10.1007/s41999-024-00968-1.
42.
Calvani R, Picca A, Coelho-Júnior HJ, et al. Diet for the prevention and management of sarcopenia. Metabolism 2023; 146: 155637, DOI: 10.1016/j.metabol.2023.155637.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.